Inventor · disambiguated record
Han-Jie Zhou
Also filed as: ZHOU HAN · ZHOU HAN-JIE
41 granted patents·24 pending applications·430 citations·filing 2002–2024
98Inventor score
Files withESSA PHARMA INC18ONYX THERAPEUTICS INC14CLEAVE BIOSCIENCES INC9CYTOKINETICS INC4QIAN XIANGPING4
Top patents by PatentIndex Score
65 records- 0198US11358938B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Jun 14, 2022·8 cites·26 claims
- 0298US11242324B2Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Granted Feb 8, 2022·9 cites·25 claims
- 0398US7691852B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2007·Granted Apr 6, 2010·65 cites·4 claims
- 0497US11518747B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Dec 6, 2022·6 cites·30 claims
- 0597US11059795B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2020·Granted Jul 13, 2021·12 cites·25 claims
- 0697US8431571B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Apr 30, 2013·33 cites·46 claims
- 0797US8357683B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2011·Granted Jan 22, 2013·34 cites·22 claims
- 0897US7687456B2Compounds for enzyme inhibitionPROTEOLIX INC·Filed 2006·Granted Mar 30, 2010·67 cites·49 claims
- 0996US8080576B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·37 cites·30 claims
- 1096US8080545B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·35 cites·17 claims
- 1194US11814357B2Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2022·Granted Nov 14, 2023·1 cites·22 claims
- 1294US11485713B2Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Granted Nov 1, 2022·10 cites·28 claims
- 1390US8716322B2Compounds for enzyme inhibitionZHOU HAN-JIE·Filed 2006·Granted May 6, 2014·17 cites·200 claims
- 1490US8609654B1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 17, 2013·8 cites·60 claims
- 1589US9512380B2Hindered phenol compound, preparation thereof and use thereof as an antioxidantCHINA PETROLEUM & CHEM CORP·Filed 2014·Granted Dec 6, 2016·6 cites·18 claims
- 1689US9205125B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·48 claims
- 1789US9205126B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·40 claims
- 1889US9205124B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 8, 2015·8 cites·34 claims
- 1987US7166595B2Compounds, methods and compositionsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 23, 2007·25 cites·18 claims
- 2085US9062026B2Fused pyrimidines and substituted quinazolines as inhibitors of p97CLEAVE BIOSCIENCES INC·Filed 2013·Granted Jun 23, 2015·6 cites·3 claims
- 2185US2024051926A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 2284US7618981B2Imidazopyridinyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2005·Granted Nov 17, 2009·7 cites·18 claims
- 2381US9828363B2Fused pyrimidines as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2015·Granted Nov 28, 2017·3 cites·20 claims
- 2479US7482343B2Compounds, methods and compositionsCYTOKINETICS INC·Filed 2006·Granted Jan 27, 2009·3 cites·17 claims
- 2578US8207340B2Imidazopyridinyl benzamide mitotic kinesin inhibitorsQIAN XIANGPING·Filed 2009·Granted Jun 26, 2012·1 cites·24 claims
- 2678US7795448B2Imidazoyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2005·Granted Sep 14, 2010·3 cites·10 claims
- 2776US8765745B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Jul 1, 2014·1 cites·100 claims
- 2874US10010554B2Fused pyrimidines as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2016·Granted Jul 3, 2018·1 cites·25 claims
- 2974US2021323931A1Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 3073US9868722B2Monocyclic pyrimidine/pyridine compounds as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2014·Granted Jan 16, 2018·1 cites·12 claims
- 3173US8865708B2Methods and compositions for inhibition of the transitional endoplasmic reticulum ATPaseDESHAIES RAYMOND J·Filed 2011·Granted Oct 21, 2014·2 cites·18 claims
- 3272US2024261282A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2024·Application pending·0 cites
- 3371US9475824B2Fused pyrimidines as inhibitors of p97 complexCLEAVE BIOSCIENCES INC·Filed 2013·Granted Oct 25, 2016·1 cites·14 claims
- 3469US8883943B2Isoolefin polymers and process for preparing the sameWU YIXIAN·Filed 2010·Granted Nov 11, 2014·2 cites·10 claims
- 3569US2022380325A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 3668US8163919B2Imidazopyridinyl benzamide mitotic kinesin inhibitorsQIAN XIANGPING·Filed 2009·Granted Apr 24, 2012·0 cites·24 claims
- 3768US2008255182A1Certain chemical entities, compositions, and methodsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 3867US8772507B2Imidazole-benzamide anti-cancer agentsQIAN XIANGPING·Filed 2012·Granted Jul 8, 2014·0 cites·19 claims
- 3967US2020123117A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2019·Application pending·0 cites
- 4066US10150794B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·0 cites·1 claims
- 4166US2014100169A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4266US2014080753A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4366US2022105093A1Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereofESSA PHARMA INC·Filed 2021·Application pending·0 cites
- 4465US8735441B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted May 27, 2014·0 cites·26 claims
- 4564US9932240B2Method for producing zeolite crystals and/or zeolite-like crystalsHEDLUND JONAS·Filed 2014·Granted Apr 3, 2018·1 cites·11 claims
- 4664US2012283287A1Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2012·Application pending·0 cites
- 4763US8937138B2Initiating system for cationic polymerization and polymerization processWU YIXIAN·Filed 2010·Granted Jan 20, 2015·1 cites·13 claims
- 4862US2023373934A1Androgen receptor modulators and methods for their useESSA PHARMA INC·Filed 2023·Application pending·0 cites
- 4962US2013130968A1Compounds for enzyme inhibitionOnyx Therapeutics·Filed 2013·Application pending·0 cites
- 5061US9657058B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·0 cites·15 claims
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Han-Jie Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →